Nature Protocols General Biochemistry, Genetics and Molecular Biology

Robust analytical methods for bis(monoacylglycero)phosphate profiling in health and disease

Dong, Wentao, Nyame, Kwamina, Rawat, Eshaan S., Medoh, Uche N., Xiong, Jian, Bonin, Caio C., Alsohybe, Hisham N., Liu, Hunter Y., Gomes, Sara, Shalit, Tammy, Arnold, Marianna, Hsieh, Frank, Sammler, Esther, Abu-Remaileh, Monther
Springer Nature · 2026-11-01 · DOI 10.1038/s41596-026-01379-1

Abstract

Bis(monoacylglycero)phosphates (BMPs) are a unique class of lipids that are dysregulated in some neurodegenerative diseases. They are structurally similar to phosphatidylglycerols (PGs); therefore, separation and identification are challenging. This protocol uses liquid chromatography–tandem mass spectrometry (MS2) to analyze cell and tissue samples. Many BMPs can be identified using positive-mode MS2 fragmentation patterns. Samples from CLN5 knockout and wild-type cells can be compared to confidently annotate BMPs. Bis(monoacylglycero)phosphate (BMP) is an anionic phospholipid found in late endosomes and lysosomes that is dysregulated in an array of diseases. This protocol describes LC/MS analysis of BMP using critical biological control samples. Bis(monoacylglycero)phosphates (BMPs), a distinct class of anionic phospholipids predominantly found in late endosomes and lysosomes, plays a pivotal role in supporting lysosomal functions and maintaining metabolic homeostasis. Dysregulation of BMPs is associated with an array of disorders, notably neurodegenerative diseases. However, the identification and quantitation of BMP remains difficult because of its structural similarity to its isomer, phosphatidylglycerol (PG), thus necessitating robust analytical methods for accurate and reliable BMP profiling. In this study, we present comprehensive liquid chromatography (LC)–tandem mass spectrometry (MS2) methodologies for the precise and systematic analysis of BMP species in biological samples. We detail LC/MS methods for both an untargeted Orbitrap mass spectrometer and a targeted triple quadrupole mass spectrometer. We use differences in hydrophobicity and structure to annotate BMPs and PGs on the basis of retention time and positive-mode MS2 fragmentation patterns, respectively. Because genetic ablation of the BMP synthase CLN5 leads to specific depletion of BMPs but not PGs, lipid extracts from CLN5 knockout and wild-type cells can be compared to confidently annotate BMPs when MS2 data are incomplete. Lipid extraction and preparation of samples for LC/MS takes ~4 h, unattended LC/MS instrument time depends on the number of samples and computer-based data analysis takes ~1 d. Altogether, this approach constitutes a robust method for BMP profiling and annotation, furthering research into health and disease.

Read at publisher →